Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA -Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024
| BOLD Stock | USD 2.62 0.08 2.96% |
About 61% of Boundless Bio,'s investor base is looking to short. The analysis of the overall investor sentiment regarding Boundless Bio, Common suggests that many traders are alarmed. The current market sentiment, together with Boundless Bio,'s historical and current headlines, can help investors time the market. In addition, many technical investors use Boundless Bio, Common stock news signals to limit their universe of possible portfolio assets.
Boundless |
Boundless Bio , a clinical-stage oncology company interrogating extrachromosomal DNA biology to deliver transformative therapies
Read at businesswire.com
 |
Boundless Bio, Fundamental Analysis
We analyze Boundless Bio,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Boundless Bio, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Boundless Bio, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Boundless Bio, is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Boundless Bio, Common Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Boundless Bio, stock to make a market-neutral strategy. Peer analysis of Boundless Bio, could also be used in its relative valuation, which is a method of valuing Boundless Bio, by comparing valuation metrics with similar companies.
Peers
Boundless Bio, Related Equities
| APGE | Apogee Therapeutics, | 2.65 | ||||
| UG | United Guardian | 1.61 | ||||
| CAH | Cardinal Health | 1.48 | ||||
| CNLFF | Canlan Ice | 0.00 | ||||
| HOFT | Hooker Furniture | 1.56 | ||||
| GNFT | Genfit | 1.84 | ||||
| SAIA | Saia | 2.77 |
Complementary Tools for Boundless Stock analysis
When running Boundless Bio,'s price analysis, check to measure Boundless Bio,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boundless Bio, is operating at the current time. Most of Boundless Bio,'s value examination focuses on studying past and present price action to predict the probability of Boundless Bio,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boundless Bio,'s price. Additionally, you may evaluate how the addition of Boundless Bio, to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |